[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@CheckOrphan Avatar @CheckOrphan Rare Diseases

Rare Diseases posts on X about dyne therapeutics, japan, oneyear, longterm the most. They currently have XXXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXXXXX #

Followers Line Chart

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence #


Social category influence stocks countries

Social topic influence dyne therapeutics, japan, oneyear, longterm, $abbv, people with, $4528t

Top assets mentioned Dyne Therapeutics, Inc. Common Stock (DYN) AbbVie Inc (ABBV)

Top Social Posts #


Top posts by engagements in the last XX hours

"Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 in Duchenne Muscular Dystrophy - For More Information Visit @Dyne_tx #Duchenne #Muscular_Dystrophy #Rare_Diseases"
X Link @CheckOrphan 2025-09-29T16:28Z 18.1K followers, XXX engagements

"Rocket Pharmaceuticals Reports FDA Acceptance of BLA Resubmission for KRESLADI to Treat Severe Leukocyte Adhesion Deficiency-I (LAD-I) - For More Information Visit @RocketPharma #LAD_I #FDA #Rare_Diseases #OrphanDrugs #Drug_Research"
X Link @CheckOrphan 2025-10-15T15:00Z 18.1K followers, XX engagements

"CSL Vifor and Travere Therapeutics Highlight Inclusion of FILSPARI in Updated 2025 KDIGO Guidelines for IgA Nephropathy Treatment - For More Information Visit @CSL @TravereRare #Rare_Diseases #OrphanDrugs #IgANephropathy #IgAN #Drug_research"
X Link @CheckOrphan 2025-09-26T12:39Z 18.1K followers, XXX engagements

"NEJM Publishes Study Showing How Regenerons DB-OTO Restored Hearing in XX of XX Children with Profound Genetic Hearing Loss - For More Information Visit @Regeneron #Hearing_Loss #FDA #NEJM #Rare_Diseases #OrphanDrugs #Pediatrics"
X Link @CheckOrphan 2025-10-13T12:43Z 18.1K followers, XXX engagements

"Dyne Therapeutics Reports One-Year Data Showing Meaningful Functional Gains with Z-Basivarsen in Myotonic Dystrophy Type X (DM1) - For More Information Visit @Dyne_tx #DM1 #Rare_Diseases #Myotonic_Dystrophy #OrphanDrugs #Drug_research"
X Link @CheckOrphan 2025-10-07T15:11Z 18.1K followers, XXX engagements

"Ipsen Wins Japanese Approval for Bylvay to Treat Pruritus in Children with Rare Liver Disorder Progressive Familial Intrahepatic Cholestasis (PFIC) - For More Information Visit #Rare_diseases #PFIC #progressive_Familial_Intrahepatic_Cholestasis"
X Link @CheckOrphan 2025-09-19T13:48Z 18.1K followers, XXX engagements

"Neurocrine Biosciences: INGREZZA Achieves Robust Symptomatic Remission in Tardive Dyskinesia Patients in KINECT-PRO Phase X Study - For More Information Visit @neurocrine #INGREZZA #Rare_Diseases #OrphanDrugs #Tardive_Dyskinesia #Drug_Research"
X Link @CheckOrphan 2025-09-23T13:02Z 18.1K followers, XXX engagements

"argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG - For More Information Visit @argenxglobal #MyastheniaGravis #FDA #Rare_Diseases #OrphanDrugs #Drug_Discovery #VYVGART"
X Link @CheckOrphan 2025-08-25T14:21Z 18.1K followers, XXX engagements

"Neurocrine Biosciences Reports Three-Year Data Showing Sustained Chorea Improvement and Long-Term Safety of INGREZZA in Huntingtons Disease - For More Information Visit @neurocrine #HuntingtonDisease #Rare_Diseases #OrphanDrugs"
X Link @CheckOrphan 2025-10-06T13:45Z 18.1K followers, XXX engagements

"AbbVie Submits Biologics License Application to FDA for Pivekimab Sunirine (PVEK) in Rare Blood Cancer BPDCN - For More Information Visit @abbvie #Rare_diseases #Blood_Cancer #BPDCN"
X Link @CheckOrphan 2025-10-01T14:19Z 18.1K followers, XXX engagements

"Novo Nordisk Submits Biologics License Application (BLA) to FDA for Mim8; An Investigational Prophylaxis Treatment for People with Hemophilia A with or without Inhibitors - For More Information Visit @novonordisk #Hemophilia #Rare_diseases"
X Link @CheckOrphan 2025-09-29T14:24Z 18.1K followers, XXX engagements

"Ono Pharmaceutical Reports Positive Interim Phase X Results for ONO-2808 in Multiple System Atrophy (MSA) - For More Information Visit @Ono_pharma_PR #Multiple_System_Atrophy #MSA #Rare_Diseases #OrphanDrugs #Drug_Research #Ono_pharma"
X Link @CheckOrphan 2025-10-10T14:19Z 18.1K followers, XXX engagements

"FDA Approves Regenerons Libtayo as First Adjuvant Immunotherapy for High-Risk Cutaneous Squamous Cell Carcinoma (CSCC) - For More Information Visit @Regeneron #CSCC #Rare_Diseases #FDA #Squamous_Cell_Carcinoma #OrphanDrugs #Libtayo"
X Link @CheckOrphan 2025-10-09T12:06Z 18.1K followers, XXX engagements